Alan G. Walton
Vorsitzender bei Biotechnology Venture Investors Group
Profil
Dr. Alan G.
Walton is Independent Director at Alexandria Real Estate Equities, Inc., Co-Founder & Senior General Partner at Oxford Bioscience Partners, and Founding Chairman at Biotechnology Venture Investors Group.
He is on the Board of Directors at Alexandria Real Estate Equities, Inc., Research!America, and NetGenics, Inc.
Prior to co-founding Oxford Bioscience Partners in 1992, Dr. Walton was President and CEO of University Genetics Co., a public biotechnology company involved in technology transfer and seed investments in university-related projects.
Prior to University Genetics, he taught at several prestigious institutions including Harvard Medical School, Indiana University and Case Western Reserve, where he was Professor of Macromolecular Science and Director of the Laboratory for Biological Macromolecules.
He was a founder of Human Genome Sciences and GeneLogic and is the Founding Chairman of the Biotechnology Venture Investors Group.
Dr. Walton serves on the Boards of Acadia Pharmaceuticals, Alexandria Real Estate Equities and is Chairman, as well as a Board member, of Avalon Pharmaceuticals.
He is also on the Board of Research America, a philanthropic organization.
Dr Watson received his PhD in chemistry and a DSc in biological chemistry from Nottingham University in England.
Aktive Positionen von Alan G. Walton
| Unternehmen | Position | Beginn |
|---|---|---|
Research!America
 Research!America Miscellaneous Commercial ServicesCommercial Services Research!America is a lobbying firm. The non-profit company is based in Alexandria, VA. The CEO of the company is Mary Woolley. | Direktor/Vorstandsmitglied | - |
| Biotechnology Venture Investors Group | Vorsitzender | - |
NetGenics, Inc.
 NetGenics, Inc. Packaged SoftwareTechnology Services NetGenics, Inc. develops software solutions for life science research. The firm provides bioinformatics solutions including the use of information technology by life science research companies to convert massive amounts of data into useful information that their scientists can then use in the development of new drugs, gene therapies, and agricultural products. The company was founded in 1996 and is headquartered in Cleveland, OH. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Alan G. Walton
| Unternehmen | Position | Ende |
|---|---|---|
Oxford Bioscience Partners
 Oxford Bioscience Partners Investment ManagersFinance Oxford Bioscience Partners is an Independent Venture Capital firm founded in 1992 by Edmund Martin Olivier, Alan G. Walton and Cornelius T. Ryan. The firm is headquartered in Boston. | Gründer | 04.07.2015 |
| ACADIA PHARMACEUTICALS INC. | Direktor/Vorstandsmitglied | 30.04.2010 |
| OCATA THERAPEUTICS INC | Direktor/Vorstandsmitglied | 26.05.2008 |
Avalon Pharmaceuticals, Inc.
 Avalon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Avalon Pharmaceuticals, Inc. was a biopharmaceutical company focused on the discovery, development and commercialization of cancer therapeutics. The company was founded in November 1999 and headquartered in Germantown, MD. | Gründer | 01.11.2007 |
Case Western Reserve University
 Case Western Reserve University Other Consumer ServicesConsumer Services Case Western Reserve University provides educational services. It offers a variety of undergraduate degree courses and graduate and professional options such as arts and sciences, dentistry, engineering, law, management, medicine, nursing, social work, and more. The firm also offers dual-degree programs. The company was founded in 1826 and is headquartered in Cleveland, OH. | Corporate Officer/Principal | 01.01.1981 |
Ausbildung von Alan G. Walton
| The University of Nottingham | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ALEXANDRIA REAL ESTATE EQUITIES, INC. | Finance |
| ACADIA PHARMACEUTICALS INC. | Health Technology |
| Private Unternehmen | 9 |
|---|---|
Oxford Bioscience Partners
Oxford Bioscience Partners Investment ManagersFinance Oxford Bioscience Partners is an Independent Venture Capital firm founded in 1992 by Edmund Martin Olivier, Alan G. Walton and Cornelius T. Ryan. The firm is headquartered in Boston. | Finance |
Astellas Institute for Regenerative Medicine
 Astellas Institute for Regenerative Medicine Pharmaceuticals: MajorHealth Technology Astellas Institute for Regenerative Medicine engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine. The company also have a preclinical development pipeline in areas outside of ophthalmology, including; autoimmune diseases, inflammatory diseases, and wound healing. The company was founded on May 18, 2000 and is headquartered in Marlborough, MA. | Health Technology |
Avalon Pharmaceuticals, Inc.
Avalon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Avalon Pharmaceuticals, Inc. was a biopharmaceutical company focused on the discovery, development and commercialization of cancer therapeutics. The company was founded in November 1999 and headquartered in Germantown, MD. | Health Technology |
Research!America
Research!America Miscellaneous Commercial ServicesCommercial Services Research!America is a lobbying firm. The non-profit company is based in Alexandria, VA. The CEO of the company is Mary Woolley. | Commercial Services |
University Genetics Co.
 University Genetics Co. Finance/Rental/LeasingFinance University Genetics Co. provides financing services to universities for research on genetic-engineering technologies. | Finance |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
| Biotechnology Venture Investors Group | |
Gene Logic, Inc.
 Gene Logic, Inc. BiotechnologyHealth Technology Gene Logic, Inc. provides drug discovery and development services to pharmaceutical and biotechnology companies worldwide. The company operates in three segments: Genomics and Toxicogenomics Services, Preclinical Contract Research Services, and Drug Repositioning and Selection Services. Gene Logic was incorporated in 1994 and is headquartered in Gaithersburg, Maryland. | Health Technology |
NetGenics, Inc.
NetGenics, Inc. Packaged SoftwareTechnology Services NetGenics, Inc. develops software solutions for life science research. The firm provides bioinformatics solutions including the use of information technology by life science research companies to convert massive amounts of data into useful information that their scientists can then use in the development of new drugs, gene therapies, and agricultural products. The company was founded in 1996 and is headquartered in Cleveland, OH. | Technology Services |
